Literature DB >> 30415189

Pinellia pedatisecta lectin exerts a proinflammatory activity correlated with ROS-MAPKs/NF-κB pathways and the NLRP3 inflammasome in RAW264.7 cells accompanied by cell pyroptosis.

Wei Wang1, Shanhu Mao1, Hongli Yu2, Hao Wu3, Xuelian Shan1, Xingde Zhang4, Guojing Cui5, Xianqiong Liu6.   

Abstract

Pinellia pedatisecta, a widely used herb in Chinese medicine, has proinflammatory toxicity related to its Pinellia pedatisecta lectin (PPL), but the mechanism is still unknown. However, for safer use, it is necessary to clarify its proinflammatory mechanism. Herein, we studied the mechanism in RAW264.7 cells. PPL decreased the mitochondrial membrane potential (MMP) and increased the outflow of calcium, accompanied by the overproduction of reactive oxygen species (ROS), which resulted in the activation of the MAPK and NF-κB pathways and the release of IL-1β. The maturation of IL-1β relied on caspase-1 p20, the active caspase-1, as demonstrated by adding caspase-1 inhibitor. While caspase-1 was associated with the activation of the NLRP3 inflammasome, we further found that the stimulation of PPL also contributed to the activation. In addition, TXNIP was downregulated, whereas NLRP3/caspase-1 p20/ASC was upregulated, and there was binding of TXNIP with NLRP3. There was also binding of NLRP3 with ASC and caspase-1. Further, we found that N-acetylcysteine (NAC), an ROS scavenger, could inhibit the PPL-stimulated activation of these pathways and the release of IL-1β. Moreover, PPL led to cell pyroptosis with pyknotic nuclei and plasma membrane rupture, which could be inhibited by NAC. All of these findings demonstrated an important role of ROS in the inflammation caused by PPL. Taken together, our data provide new mechanistic insights into the possible endogenous signaling pathways involved in the inflammation of RAW264.7 cells, stimulated by PPL.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IL-1β; Lectin; MAPK and NF-κB/NLRP3 pathways; Pinellia pedatisecta; Pyroptosis; ROS

Mesh:

Substances:

Year:  2018        PMID: 30415189     DOI: 10.1016/j.intimp.2018.11.002

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  Cadmium induces renal inflammation by activating the NLRP3 inflammasome through ROS/MAPK/NF-κB pathway in vitro and in vivo.

Authors:  Ziyin Li; Huiqin Chi; Wei Zhu; Guangyu Yang; Jia Song; Lijun Mo; Yitian Zhang; Yudi Deng; Feifei Xu; Jiani Yang; Zhini He; Xingfen Yang
Journal:  Arch Toxicol       Date:  2021-09-12       Impact factor: 5.153

2.  Hejie Zhitong prescription promotes sleep and inhibits nociceptive transmission-associated neurotransmitter activity in a rodent migraine model.

Authors:  Xinna Wang; Hongfei Zhao; Liming Liu; Ping Niu; Chao Zhai; Jinjian Li; Qiaoli Xu; Dexi Zhao
Journal:  Chin Med       Date:  2020-09-29       Impact factor: 5.455

3.  SJMHE1 protects against excessive iodine-induced pyroptosis in human thyroid follicular epithelial cells through a toll-like receptor 2-dependent pathway.

Authors:  Zhu Zhang; Jiameng Liu; Chaoming Mao; Shan Zhang; Xuefeng Wang; Liyang Dong
Journal:  Int J Med Sci       Date:  2022-03-21       Impact factor: 3.642

Review 4.  The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target.

Authors:  Alison Domingues; Julia Jolibois; Perrine Marquet de Rougé; Valérie Nivet-Antoine
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

5.  Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019.

Authors:  Yuanfeng Zhang; Zheyi Wang; Yue Zhang; Hongxuan Tong; Yiling Zhang; Tao Lu
Journal:  Front Mol Biosci       Date:  2020-12-14

Review 6.  The Molecular Pathways of Pyroptosis in Atherosclerosis.

Authors:  Dan Song; Manman Li; Xue Yu; Yuqin Wang; Jiaying Fan; Wei Yang; Liming Yang; Hong Li
Journal:  Front Cell Dev Biol       Date:  2022-02-14

Review 7.  Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?

Authors:  Na Jiang; Jinjin Liu; Conghui Guan; Chengxu Ma; Jinyang An; Xulei Tang
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.